Day-Case Surgery: Enhanced Recovery with Flumazenil
Author(s) -
Brian Birch,
Ken Anson,
Elizabeth Farrell Clifford,
Ronald Miller
Publication year - 1990
Publication title -
journal of the royal society of medicine
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.38
H-Index - 81
eISSN - 1758-1095
pISSN - 0141-0768
DOI - 10.1177/014107689008300709
Subject(s) - flumazenil , medicine , surgery , anesthesia , computer science , benzodiazepine , receptor
In an open, randomized, parallel group study of 84 adult patients undergoing elective day-case urological surgery the specific benzodiazepine antagonist flumazenil was shown to reverse effectively subjective postoperative sedation due to midazolam and enabled 83% of patients to recover and be ready for potential discharge within 15 min of surgery (control group 24% p less than 0.001). The significantly shorter recovery time has benefits in terms of increased patient cooperation and reduced demands on postoperative nursing care. The implications of these findings for day-case surgery are discussed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom